No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis

Journal of Neuroimmunology

Volumn 91, Issue 1-2, 1998, Pages 108-112

  Kivisäkk, Pia ^a   Teleshova, Natalia ^a   Özenci, Volkan ^a   Huang, Yumin ^a   Matusevicius, Darius ^a   Fredrikson, Sten ^a   Söderström, Mats ^a   Link, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chemokines; MCP 1; Multiple sclerosis; RANTES

Indexed keywords

CHEMOKINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; DEMYELINATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; CHEMOKINE CCL2; FEMALE; GENE EXPRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RANTES; RNA, MESSENGER;

EID: 0032476568     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00158-1     Document Type: Article

References (24)

1. Berman J.W., Guida M.P., Warren J., Amat J., Brosnan C.F. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J. Immunol. 156:1996;3017-3023.
2. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 272:1996;60-66.
3. 14C -labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis Lab. Invest. 63:1990;162-170.
4. Glabinski A.R., Tani M., Strieter R.M., Tuohy V.K., Ransohoff R.M. Synchronous synthesis of α- and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150:1997;617-630.
5. Godiska R., Chantry D., Dietsch G.N., Gray P.W. Chemokine expression in murine experimental allergic encephalomyelitis. J. Neuroimmunol. 58:1995;167-176.
6. Hartung, H.P., 1997. Pathogenesis of multiple sclerosis. In: Abramsky, O., Ovadia, H. (Eds.), Frontiers in Multiple Sclerosis: Clinical Research and Therapy. Matrin Dunitz, London, pp. 45-59.
7. Hickey W.F., Hsu B.L., Kimura H. T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28:1991;254-260.
8. Hulkower K., Brosnan C.F., Aquino D.A., Cammer W., Kulshrestha S., Guida M.P., Rapoport D.A., Berman J.W. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J. Immunol. 150:1993;2525-2533.
9. Hvas J., McLean C., Justesen J., Kannourakis G., Steinman L., Oksenberg J.R., Bernard C.C.A. Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions. Scand. J. Immunol. 46:1997;195-203.
10. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
11. Link J., Söderström M., Olsson T., Höjeberg B., Ljungdahl Å., Link H. Increased transforming growth factor-β, interleukin-4 and interferon-γ in multiple sclerosis. Ann. Neurol. 36:1994;379-386.
12. Lucchinetti C.F., Brück W., Rodriguez M., Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol. 6:1996;259-274.
13. Miyagishi R., Kikuchi S., Fukazawa T., Tashiro K. Macrophage inflammatory protein-1α in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J. Neurol. Sci. 129:1995;223-227.
14. Navikas V., Link H. Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:1996;322-333.
15. Olsson T., Kostulas V., Link H. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification. Clin. Chem. 30:1984;1246-1249.
16. Osserman K.E., Genkins G. Studies in myasthenia gravis: review of a twenty year experience in over 1200 patients. M. Sinai J. Med. (NY). 38:1973;497-537.
17. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtelotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
18. Ransohoff R.M., Hamilton T.A., Tani M., Stoler M.H., Shick H.E., Major J.A., Estes M.L., Thomas D.M., Tuohy V.K. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7:1993;592-600.
19. Ransohoff R.A., Glabinski A., Tani M. Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev. 7:1996;35-46.
20. Rollins B.J. Chemokines. Blood. 90:1997;909-928.
21. Schall T.J., Bacon K., Toy K.J., Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 347:1990;669-671.
22. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
23. Taub D.D., Sayers T.J., Carter C.R., Ortaldo J.R. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155:1995;3877-3888.
24. Valente A.J., Graves D.T., Vialle-Valentin C.E., Delgado R., Schwarz C.J. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry. 27:1988;4162-4168.